Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the validity and safety of an MRI contrast agent injected intraocularly? (IOP) for hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma [Phase 2]
Phase 2 study of milciclib in unresectable/metastatic hepatocellular carcinoma completed.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2) [Phase 2]
Phase 2 trial update for stereotactic body radiation therapy in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis [Phase 2]
A Phase 2 proof-of-concept study evaluating the efficacy of P03277 MR imaging for diagnosing hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study [Phase 2]
Phase II single-arm trial evaluating TACE combined with sintilimab and a bevacizumab biosimilar in hepatocellular carcinoma (BCLC-C).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC [Phase 3]
Phase 3 trial evaluating toripalimab in combination with lenvatinib and TACE as conversion therapy for potentially resectable hepatocellular…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating the combination of transarterial chemoembolization (TACE) with lenvatinib for unresectable hepatoce…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: PD-1 Antibody and Lenvatinib Plus TACE-HAIC for Potential Resectable HCC: a Single-arm, Phase 2 Clinical Trial [Phase 2]
A single-arm Phase 2 clinical trial evaluating PD-1 antibody plus lenvatinib and TACE-HAIC for potentially resectable hepatocellular carcino…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria [NA]
A terminated clinical trial comparing proton radiotherapy plus sorafenib to sorafenib alone for hepatocellular carcinoma beyond the San Fran…
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis [Phase 4]
Phase 4 clinical trial evaluating radiotherapy plus donafenib as neoadjuvant therapy for hepatocellular carcinoma with portal vein tumor thr…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating camrelizumab plus lenvatinib with TACE for borderline resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI [NA]
Clinical trial update on adjuvant radiotherapy after surgical resection for hepatocellular carcinoma with microvascular invasion has complet…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating galunisertib in combination with nivolumab for advanced solid tumors, including recurrent or refractory non-small…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]
A phase 1/2 trial evaluating BBI608 or BBI503 in combination with sorafenib in adults with hepatocellular carcinoma has completed, with resu…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial updating the combination of PD-1 and VEGFR-2 blockade for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update evaluating cryoablation with camrelizumab and apatinib in advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3435151 in Participants With Solid Tumors [Phase 1]
Phase 1 study of LY3435151 in solid tumors, including triple-negative breast cancer, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea [NA]
A completed clinical trial in Korea evaluated the safety and effectiveness of microwave ablation for hepatocellular carcinoma; results have …
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy [Phase 2]
Phase 2 clinical trial update evaluating hepatic artery infusion chemotherapy for unresectable hepatocellular carcinoma after failure of sys…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer [Phase 2]
Phase 2 study evaluating pegylated recombinant human arginase 1 as second-line therapy for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT [Phase 4]
A Phase 4 study comparing lenvatinib plus transarterial chemoembolization (TACE) versus sorafenib plus TACE for hepatocellular carcinoma wit…
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation [Phase 2]
Phase 2 randomized study evaluating doxorubicin delivered by drug-eluting bead embolisation for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-14Clinical Trial Update: The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 trial update evaluating hepatic arterial infusion chemotherapy combined with lenvatinib and durvalumab for advanced hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Tenofovir Alafenamide(TAF) Reduces the Risk of Hepatocellular Carcinoma(HCC) Recurrence [Phase 4]
A Phase 4 trial update suggests tenofovir alafenamide (TAF) reduces recurrence risk of hepatocellular carcinoma after curative treatment in …
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020） [Phase 2]
Phase 2 trial update evaluating carelizumab in combination with regorafenib for hepatocellular carcinoma.